Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-26

Clinical Trial Update: DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy [Phase 4]

View source ↗

Summary

DART II is a Phase IV study evaluating a three-drug antiretroviral combination in HIV patients who have not previously received antiretroviral therapy, and the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections, AIDS | Phase 4 | Status: COMPLETED